Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Environmental Monitoring During Gel Production – V 2.0

Posted on By

Gel Manufacturing: SOP for Environmental Monitoring During Gel Production – V 2.0

Standard Operating Procedure for Environmental Monitoring During Gel Production in Gel Manufacturing


Department Gel Manufacturing
SOP No. SOP/GM/129/2025
Supersedes SOP/GM/129/2022
Page No. Page 1 of 12
Issue Date 09/06/2025
Effective Date 11/06/2025
Review Date 09/06/2027

1. Purpose

To establish a standardized procedure for environmental monitoring (EM) of the manufacturing area during gel production, ensuring adherence to GMP, microbial control standards, and contamination prevention protocols.

2. Scope

This SOP applies to all manufacturing and critical processing areas within the gel production unit where

environmental monitoring is required, including cleanrooms, HVAC-controlled zones, and sterile compounding areas.

3. Responsibilities

  • Microbiology Executive: Executes EM sampling, records results, and alerts QA of deviations.
  • Production Supervisor: Facilitates sample collection and coordinates with QC.
  • QA Executive: Reviews results and trends for OOS or OOT events and takes corrective action.
See also  Gel Manufacturing: SOP for Dispensing Active Pharmaceutical Ingredients (APIs) for Gels - V 2.0

4. Accountability

Department Head – Quality Control and Department Head – Manufacturing

5. Procedure

5.1 Types of Environmental Monitoring

  1. Airborne particulate monitoring using laser particle counters.
  2. Microbial air monitoring through settle plates and active air samplers.
  3. Surface monitoring using contact plates or swab tests.
  4. Personnel monitoring via finger dab or gown sampling.

5.2 Monitoring Frequency

  1. Daily: Settle plates in Class 100/ISO 5 and Class 1000/ISO 6 zones during production.
  2. Weekly: Surface and personnel monitoring in Class 100–10000 zones.
  3. Monthly: Comprehensive area trend analysis and HVAC system output validation.

5.3 Sampling Locations

  1. Defined using risk-based approach (e.g., filling areas, compounding tanks, laminar flow hoods).
  2. EM location map to be maintained and verified periodically.

5.4 Procedure for Sampling

  1. Prepare settle plates labeled with date, time, location, and operator initials.
  2. Place plates for 4 hours under ISO 5 hoods; 2 hours in ISO 7/8 areas.
  3. For swabbing, use sterile swabs moistened with diluent and cover 25 cm² area.
  4. Transfer samples to microbiology lab within 1 hour of collection.
See also  Gel Manufacturing: SOP for Managing Breakdowns of Gel Manufacturing Equipment - V 2.0

5.5 Acceptance Criteria

  1. Follow Grade A–D classification limits as per EU GMP Annex 1 and WHO guidelines.
  2. Trend evaluation to be performed monthly and included in EM summary reports.

5.6 Deviation and Corrective Action

  1. Any OOS or OOT observation shall be reported to QA immediately.
  2. Investigations shall be conducted using root cause analysis tools.
  3. CAPA shall be implemented before resuming production in affected area.

5.7 Documentation

  1. EM Logs – Annexure-1
  2. EM Summary Reports – Annexure-2
  3. EM Deviation Form – Annexure-3

6. Abbreviations

  • EM: Environmental Monitoring
  • OOS: Out of Specification
  • OOT: Out of Trend
  • CAPA: Corrective and Preventive Action
  • GMP: Good Manufacturing Practices

7. Documents

  1. EM Log Sheet – Annexure-1
  2. EM Trend Summary Report – Annexure-2
  3. EM Deviation & Investigation Form – Annexure-3
See also  Gel Manufacturing: SOP for Monitoring Cross-Contamination in Gel Manufacturing - V 2.0

8. References

  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • WHO TRS 961: Good Manufacturing Practices for Pharmaceuticals
  • ISO 14644: Cleanroom and Associated Controlled Environments

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Environmental Monitoring Log Sheet

Date Area Location Method Result Limits Initials

Annexure-2: EM Summary Report Format

Month Area Total Samples OOS Count OOT Count Remarks

Annexure-3: EM Deviation & Investigation Form

Reference No.
Date
Location
OOS/OOT Observation
Root Cause
CAPA
Closure Date

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/02/2022 1.0 Initial release New SOP QA Head
09/06/2025 2.0 Updated sampling frequency and included risk-based approach Annual revision QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Biosimilars: SOP for Centrifuge Operation for Cell Removal – V 2.0
Next Post: Formulation Development: SOP for Documentation in Product Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version